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ABSTRACT
Objectives In the UK, 20% of patients with severe 
traumatic brain injury (TBI) receive prehospital emergency 
anaesthesia (PHEA). Current guidance recommends an 
end- tidal carbon dioxide (ETCO2) of 4.0–4.5 kPa (30.0–
33.8 mm Hg) to achieve a low- normal arterial partial 
pressure of CO2 (PaCO2), and reduce secondary brain 
injury. This recommendation assumes a 0.5 kPa (3.8 mm 
Hg) ETCO2–PaCO2 gradient. However, the gradient in 
the acute phase of TBI is unknown. The primary aim was 
to report the ETCO2–PaCO2 gradient of TBI patients at 
hospital arrival.
Methods A retrospective cohort study of adult patients 
with serious TBI, who received a PHEA by a prehospital 
critical care team in the East of England between 1 
April 2015 and 31 December 2017. Linear regression 
was performed to test for correlation and reported as 
R- squared (R2). A Bland- Altman plot was used to test for 
paired ETCO2 and PaCO2 agreement and reported with 
95% CI. ETCO2–PaCO2 gradient data were compared 
with a two- tailed, unpaired, t- test.
Results 107 patients were eligible for inclusion. Sixty- 
seven patients did not receive a PaCO2 sample within 
30 min of hospital arrival and were therefore excluded. 
Forty patients had complete data and were included in 
the final analysis; per protocol. The mean ETCO2–PaCO2 
gradient was 1.7 (±1.0) kPa (12.8 mm Hg), with 
moderate correlation (R2=0.23, p=0.002). The Bland- 
Altman bias was 1.7 (95% CI 1.4 to 2.0) kPa with upper 
and lower limits of agreement of 3.6 (95% CI 3.0 to 
4.1) kPa and −0.2 (95% CI −0.8 to 0.3) kPa, respectively. 
There was no evidence of a larger gradient in more 
severe TBI (p=0.29). There was no significant gradient 
correlation in patients with a coexisting serious thoracic 
injury (R2=0.13, p=0.10), and this cohort had a larger 
ETCO2–PaCO2 gradient, 2.0 (±1.1) kPa (15.1 mm Hg), 
p=0.01. Patients who underwent prehospital arterial 
blood sampling had an arrival PaCO2 of 4.7 (±0.2) kPa 
(35.1 mm Hg).
Conclusion There is only moderate correlation of 
ETCO2 and PaCO2 at hospital arrival in patients with 
serious TBI. The mean ETCO2–PaCO2 gradient was 1.7 
(±1.0) kPa (12.8 mm Hg). Lower ETCO2 targets than 
previously recommended may be safe and appropriate, 
and there may be a role for prehospital PaCO2 
measurement.
BACKGROUND
Traumatic brain injury (TBI) is the leading cause 
of death and disability following trauma, with 
69 million estimated new cases each year world-
wide.1 Optimising cerebral blood flow (CBF) is 
the mainstay of treatment to prevent secondary 
brain injury and reduce mortality.2 Early manage-
ment of raised intracranial pressure (ICP) includes 
controlled ventilation via prehospital emergency 
anaesthesia (PHEA).3 A growing number of emer-
gency medical services are providing this.4 At 
present, it is estimated that one in five patients with 
severe TBI undergo PHEA.5
The use of end- tidal capnography to confirm 
endotracheal tube position is widely accepted.6 
Current guidance encourages the use of end- tidal 
carbon dioxide (ETCO2) as a surrogate for the arte-
rial partial pressure of carbon dioxide (PaCO2) to 
guide ventilation.7 8 Under normal physiological 
Key messages
What is already known on this subject
 ► The optimal management of ventilation in 
patients with serious traumatic brain injury 
(TBI) reduces secondary brain insult.
 ► Current guidance recommends the use 
of end- tidal carbon dioxide (ETCO2) as a 
surrogate for arterial carbon dioxide (PaCO2) 
to guide ventilation strategy in the prehospital 
environment.
 ► The effect of the ETCO2–PaCO2 gradient on 
resultant PaCO2 early in this disease process is 
unknown.
What this study adds
 ► This retrospective cohort study of 40 patients 
receiving prehospital emergency anaesthesia 
found only moderate correlation of ETCO2 and 
PaCO2 in patients with serious TBI, thus the use 
of ETCO2 to guide ventilation is a blunt tool in 
this cohort.
 ► The ETCO2–PaCO2 gradient is larger than 
previously reported and is increased by the 
presence of coexisting thoracic injuries. 
Prehospital PaCO2 measurement resulted in 
more accurate titration of ventilatory strategy.
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conditions, alveolar dead space accounts for a 0.5 kPa (3.8 mm 
Hg) ETCO2–PaCO2 gradient in ventilated patients.
9 In- hospital 
data demonstrate good correlation in patients with TBI.10–12 The 
Association of Anaesthetists recommend an ETCO2 target of 
4.0–4.5 kPa (30.0–33.8 mm Hg) to achieve normocapnia.7
The mechanisms of autoregulation of CBF differ with changes 
in ICP.13 Respiratory dysfunction and loss of autoregulation is 
common in patients with TBI,14 and a 1% change in PaCO2 can 
lead to changes of up to 4% in CBF.15 Prehospital data evaluating 
the use of ETCO2 are limited, but are not consistent with in- hos-
pital findings; leading to some criticism of the use of ETCO2 to 
guide ventilation.16–18 In most cases of TBI, an increase in ICP 
evolves over hours, and therefore moderate hypercapnia prehos-
pital would be expected to increase CBF. However, the effect 
of the ETCO2–PaCO2 gradient on resultant PaCO2 early in this 
disease process is unknown. The primary objective of this study 
was to report the ETCO2–PaCO2 gradient at hospital arrival in a 
cohort of patients with serious TBI who underwent PHEA.
Hypothesis
Patients with serious TBI who undergo PHEA have an ETCO2–
PaCO2 gradient greater than 0.5 kPa (3.8 mm Hg).
METHODS
In this retrospective observational study, a convenience sample 
of patients who underwent PHEA by a single UK prehospital 
team (East Anglian Air Ambulance, EAAA) between 1 April 2015 
and 31 December 2017 was extracted from the EAAA electronic 
medical record.
Prehospital critical care team
EAAA is a medical charity that provides prehospital critical care 
to the statutory ambulance service in the East of England (East 
of England Ambulance Service NHS Trust). EAAA operates from 
two bases (Cambridge and Norwich), dispatching a physician- 
paramedic prehospital critical care team in either an H145 heli-
copter or rapid response vehicle, depending on patient location, 
weather constraints and time of day (H145 available 07:00–
23:59 in Cambridge, and 07:00–19:00 in Norwich). During the 
study period, the Cambridge EAAA base was operational from 
07:00 to 01:30 daily, and the Norwich base was operational 
24 hours per day 7 days per week with a paramedic- only service 
(without PHEA capability) from 19:00 through 07:00.
Inclusion criteria
In order to report outcomes, only patients who were primarily 
transported by EAAA to the regional neurosciences (and major 
trauma) centre (Cambridge University Hospitals NHS Founda-
tion Trust, CUH) were included. This allowed cross- reference 
of injury patterns and outcomes collated by the CUH Trauma 
Office, and also for retrieval of PaCO2 data from the CUH 
electronic medical record. Patients were included if they were 
attended by EAAA, were ≥18 years old, underwent PHEA, were 
transported to CUH from scene, had a serious (or more severe) 
TBI and had complete data. Consistent with recent large data 
methodology, patients without a PaCO2 measurement within 
30 min of hospital arrival were excluded.19
Definitions
PHEA was defined as drug- assisted endotracheal intubation in 
the prehospital setting. Serious TBI was defined as a retrospec-
tively applied Abbreviated Injury Scale (AIS) score for ‘head’≥3, 
and serious thoracic injury was defined as an AIS ≥3 for ‘thorax’.
Data collection
The side- stream ETCO2 values and BP (reported as mean arte-
rial pressure, MAP) at hospital handover were obtained from 
the EAAA electronic medical record that includes a time- 
stamped download from the prehospital monitor (ZOLL X 
Series Monitor/Defibrillator, ZOLL Medical Corporation of 
Asahi Kasei Corp., Tokyo). The in- hospital PaCO2 values were 
obtained from the CUH electronic medical record that includes a 
time- stamped download of data from an ABG analyzer (COBAS 
B 221 Blood Gas Analyzer, Roche Diagnostics, Indianapolis, IN, 
USA). ETCO2 and PaCO2 data were recorded in kilopascal (kPa) 
units; a conversion of (kPa*7.50062=mm Hg) has been used to 
present units of millimetres of mercury alongside kPa.
Demographic, mechanism of injury, injury severity (AIS and 
Injury Severity Score (ISS)), 30 day mortality and functional 
outcome (Glasgow Outcome Scale (GOS) score) data were 
obtained from the CUH Trauma Office records.
Primary outcome
The primary outcome was to report the ETCO2–PaCO2 gradient 
at hospital arrival.
Secondary outcomes
The secondary outcomes were to report the relationship between 
the severity of TBI (serious (AIS=3) and severe (AIS=4) versus 
critical (AIS=5)) and ETCO2–PaCO2 gradient at hospital arrival; 
to report the effect of a coexisting serious (AIS ≥3) thoracic 
injury on the ETCO2–PaCO2 gradient at hospital arrival; and to 
compare the PaCO2 at hospital arrival in patients that received 
prehospital arterial blood sampling.
Statistical analysis
Basic demographic, mechanism of injury and injury data have 
been reported as number (percentage) and mean (±SD) or 
median (IQR) as appropriate. ETCO2 and PaCO2 data have been 
reported as percentage (95% CI) and mean (±SD). Compar-
isons of unpaired, normally distributed, continuous variables 
were undertaken with a two- tailed unpaired t- test (with Welch’s 
correction if samples had unequal deviations).
Fisher’s exact test has been used to compare proportions. 
Linear regressions have been performed to test for correlation 
and are reported as R- squared (R2) with gradient of the slope 
(m). A Bland- Altman plot has been used to test for agreement 
between paired ETCO2 and PaCO2 data, and has been reported 
as bias (95% CI) with upper and lower limits of agreement.
Statistical analyses were performed using the R statistical 
programming language (R Core Team (2018); R: A language and 
environment for statistical computing (R Foundation for Statis-
tical Computing, Vienna, Austria); significance was predefined at 
<0.05 and no corrections were made for multiple comparisons.
Patient and public involvement
Patients or the public were not involved in the design, conduct, 
reporting or dissemination plans of our research.
RESULTS
Demographics and injury
107 patients were eligible for inclusion. Sixty- seven patients did 
not receive a PaCO2 sample within 30 min of hospital arrival and 
were therefore excluded. Forty patients had complete data and 
were included in the final analysis; per protocol. The median 
age was 45 (23–63) years, 24 (60.0%) were male. The most 
prevalent mechanism of injury was road traffic collision, n=22 
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(55.0%). The median ISS was 31 (26–38), and 97.5% of the 
cohort had an ISS ≥15. The mean hospital arrival MAP was 93.7 
(±24.4) mm Hg. Overall, 30 day mortality was 30.0% (95% CI 
16.6 to 47.9), and all survivors had a GOS ≥3 (severe disability 
or better), table 1.
ETCO2–PaCO2
Overall, the mean ETCO2 and PaCO2 were 4.1 (±0.7) kPa 
(30.7 mm Hg) and 5.8 (±1.1) kPa (43.3 mm Hg), respectively. 
In 38/40 (95.0%, 95% CI 83.5 to 98.6) patients, the PaCO2 was 
more than 0.5 kPa (3.8 mm Hg) higher than the ETCO2. No 
patients were hypocapnic (PaCO2 lower than 4.0 kPa (30.0 mm 
Hg)) and there was moderate correlation between ETCO2 and 
PaCO2 (R
2=0.23, m=0.72, p=0.002), figure 1.
Primary outcome
The mean ETCO2–PaCO2 gradient was 1.7 (±1.0) kPa (12.8 mm 
Hg), figure 1. The Bland- Altman analysis looking at the differ-
ence between PaCO2 and ETCO2 showed the bias to be 1.7 (95% 
CI 1.4 to 2.0) kPa with upper and lower limits of agreement of 
3.6 (95% CI 3.0 to 4.1) kPa and −0.2 (95% CI −0.8 to 0.3) kPa, 
respectively, figure 2.
Secondary outcomes
Severity of TBI
Patients with a critical TBI (AIS of 5), n=24 (60.0%) had a 
comparable mean ETCO2–PaCO2 gradient compared with those 
with a serious or severe (AIS=3 or 4) injury—1.8 (±1.1) kPa 
(13.5 mm Hg) and 1.5 (±0.7) kPa (11.2 mm Hg), respectively, 
p=0.29. Both of these groups (AIS=5 and AIS=3 or 4) demon-
strated a moderate correlation (R2=0.22, m=0.64, p=0.02 and 
R2=0.31, m=1.31, p=0.03, respectively).
Thoracic injury
22/40 (55.0%) patients had a serious thoracic injury. The mean 
ETCO2–PaCO2 gradient in this subgroup was 2.0 (±1.1) kPa 
(15.1 mm Hg), significantly higher than the 18/40 patients 
without a serious thoracic injury—1.3 (±0.5) kPa (9.5 mm Hg), 
p=0.01. There was no significant correlation in the thoracic 
injury subgroup (R2=0.13, m=0.54, p=0.10), but there was 
a significant correlation in the group without serious thoracic 
injury (R2=0.51, m=0.78, p<0.001). There was no significant 
difference in mean MAP at hospital arrival between patients 
with and without a serious thoracic injury—91.9 (±25.3) mm 
Hg and 95.9 (±23.7) mm Hg, respectively, p=0.60.
Prehospital PaCO2 measurement
Seven (17.5%) patients underwent prehospital measurement 
of PaCO2, using the iSTAT (Abbott Laboratories, Illinois, USA) 
point- of- care ABG (POC- ABG) analyzer. The POC- ABG group 
had a significantly lower, and more appropriate hospital arrival 
PaCO2, compared with the no- ABG group—4.7 (±0.2) kPa 
(35.1 mm Hg) versus 6.0 (±1.1) kPa (45.0 mm Hg), respectively, 
p=0.7×10−7.
DISCUSSION
This study has demonstrated that patients with an AIS ≥3 TBI 
have a larger ETCO2–PaCO2 gradient at hospital arrival than 
previously reported. The severity of TBI was not significantly 
associated with the ETCO2–PaCO2 gradient. However, the pres-
ence of a coexisting serious thoracic injury was associated with 
a significantly larger ETCO2–PaCO2 gradient, which is manifest 
as an apparent bias in the Bland- Altman plot of figure 2. In the 
Table 1 Study population demographics
N (%) or median (IQR)
Gender
  Male 24 (60.0)
  Female 16 (40.0)
Age
  Total 45 (23–63)
  Male 34 (22–62)
  Female 50 (33–66)
Mechanism of injury
  Road traffic collision 22 (55.0)
  Fall from height 17 (42.5)
  Crush injury 1 (2.5)
Injury Severity Score
  ISS >15 39 (97.5)
  ISS >25 33 (82.5)
‘Head’ Abbreviated Injury Severity
  Serious TBI (AIS 3) 8 (20.0)
  Severe TBI (AIS 4) 8 (20.0)
  Critical TBI (AIS 5) 24 (60.0)
Prehospital PaCO2 measurement
  Yes 7 (17.5)
  No 33 (82.5)
Patient outcome at 30 days
  Alive 28 (70.0)
  Dead 12 (30.0)
  Glasgow Outcome Score ≤3 24 (60.0)
  Glasgow Outcome Score ≥4 16 (40.0)
AIS, Abbreviated Injury Scale score; ISS, Injury Severity Score; PaCO2, partial pressure 
of arterial carbon dioxide; TBI, traumatic brain injury.
Figure 1 Scatter plot of the relationship between ETCO2 and PaCO2 at 
hospital arrival. 1.0kPa=7.50062 mm Hg. The ETCO2–PaCO2 gradient was 
1.7 (±1.0) kPa (12.8 mm Hg). The mean is plotted as a single line and SD 
as dashed lines. ETCO2, end- tidal carbon dioxide; PaCO2, arterial partial 
pressure of carbon dioxide.
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serious thoracic injury cohort, there was no evidence of correla-
tion between ETCO2 and PaCO2. All patients who underwent 
prehospital PaCO2 measurement had a low- normal PaCO2 at 
hospital arrival.
PaCO2 is a major determinant of CBF through its effects 
on cerebral vascular tone. Ventilatory control is crucial to the 
management of TBI.20 Even modest hypercapnia may result 
in substantial increases in ICP when intracranial compliance 
is poor.21 Conversely, even modest hyperventilation has been 
shown to lead to dangerous cerebral ischaemia,22 and this may 
be of particular importance in the first hours after TBI when 
hypoperfusion is a dominant pathology.23
Current guidance recommends an ETCO2 of 4.0–4.5 kPa 
(30.0–33.8 mm Hg) as a surrogate for a low- normal PaCO2.
7 
This guidance relies on the assumption that the ETCO2–PaCO2 
gradient is approximately 0.5 kPa (3.8 mm Hg), and is predom-
inantly extrapolated from healthy individuals. In this study, 
the mean hospital arrival ETCO2 was 4.1 (±0.7) kPa (30.7 mm 
Hg), which suggests that the prehospital providers adhered 
closely to the extant guidelines. Despite this, the mean PaCO2 
was 5.8 (±1.1) kPa (43.3 mm Hg)—far in excess of the target of 
4.5–5.0 kPa,24 owing to a mean ETCO2–PaCO2 gradient of 1.7 
(±1.0) kPa (12.8 mm Hg). The result of this is that when relying 
on ETCO2 as a surrogate, providers may not achieve an optimal 
prehospital PaCO2.
The arterial- alveolar CO2 gradient is determined by the ratio 
of physiological dead space and tidal volume. Since 2000 and 
the publication of the ARDSNet study, ventilatory practice has 
shifted towards the use of lower tidal volumes.25 Therefore, in 
contemporary practice the ETCO2–PaCO2 gradient would be 
expected to be larger because the dead space is more appreciable, 
and it may be that the target ETCO2 needs to be reconsidered. 
It is tempting to advocate a lower prehospital ETCO2—perhaps 
2.8–3.3 kPa (21.0–24.8 mm Hg) in patients suspected of having 
an AIS ≥3 TBI (assuming a gradient of 1.7 kPa (12.8 mm Hg)), 
particularly in the setting of coexisting thoracic injury. However, 
this strategy may risk hypocapnia (PaCO2 <4.0 kPa (30.0 mm 
Hg)), which in the setting of a very high ICP may be of benefit 
via hypocapnic arterial vasoconstriction,21 but in the more likely 
prehospital clinical scenario (<24 hours after TBI) of normal ICP, 
may lead to severe cerebral ischaemia and worse outcomes.26
There was only moderate correlation between ETCO2 and 
PaCO2; statistically, only 23% of the variance (R
2, the coeffi-
cient of determination) observed in ETCO2 can be explained by 
the PaCO2. There was no ETCO2–PaCO2 gradient correlation in 
the subgroup with an AIS ≥3 thoracic injury. We presume that 
this is owing to the effect of heterogeneous physiological dead 
space (caused by the thoracic injury) on the arterial- alveolar CO2 
gradient. Therefore, in those without an AIS ≥3 thoracic injury 
the ETCO2–PaCO2 gradient correlation was better; statistically 
51% of the variance observed in ETCO2 can be explained by 
PaCO2. In order to ensure that the increased gradient observed 
in the AIS ≥3 thoracic injury group was not simply due to a 
lower systemic perfusion compared with the group without 
serious thoracic injury, MAP at hospital arrival was reported 
between the two groups. Although there is a known relationship 
between tissue perfusion and ETCO2,
11 there was no difference 
between the MAP (used as a surrogate for perfusion) at hospital 
arrival between those with and without an AIS ≥3 thoracic 
injury. We think that this strengthens the theory that thoracic 
injury increases the physiological dead space. It is unclear from 
these data what variable(s) make up the remaining 49% of vari-
ance observed. We acknowledge the transfer from a prehospital 
to an in- hospital ventilator may be one factor in this. However, 
EAAA and CUH use identical ventilators (Dräger Oxylog 3000, 
Drägerwerk AG &Co., Lübeck, Germany), and it is standard 
practice to commence in- hospital ventilation using the prehos-
pital settings.
It is not necessarily surprising that in this small sample with 
significant variance we were not able to demonstrate a signif-
icant difference between the severity of TBI (as measured by 
AIS) and the ETCO2–PaCO2 gradient, and it is possible that this 
represents a type-2 error. Previous work has demonstrated an 
increased gradient in more severe injury (higher ISS), but has not 
examined head or thoracic injury specifically,16 and has shown 
an increased mortality in ‘abnormal’ hospital- arrival ETCO2.
27 
In the subgroup of patients with a serious thoracic injury, the 
ETCO2–PaCO2 gradient was significantly higher than those 
without a serious thoracic injury, further compounding the inac-
curacy in estimating PaCO2 from ETCO2 in the severely injured 
trauma patient. The patients in our study were all primarily 
transported to the regional neurosciences (and major trauma) 
centre by a prehospital critical care team. Therefore, it is possible 
that we are missing data from both ends of the severity spectrum: 
patients with a lesser injury and those with a more immediate 
requirement for in- hospital resuscitation may have been initially 
transported to a local trauma unit hospital. Our limited anal-
ysis of the effect of severity of TBI on gradient demonstrated a 
non- significant trend of increasing gradient with increasing TBI 
severity. However, the pragmatic clinical benefits of knowing 
if severity of TBI affects the ETCO2–PaCO2 gradient is mini-
mal—without good evidence of strong correlation between 
ETCO2 and PaCO2, the provider cannot rely on ETCO2 as a 
surrogate.
Inadvertent hypocapnia is an important factor in avoidable 
neuronal injury following TBI via a reduction in CBF and an 
increase in cerebral oxygen consumption.22 While we have 
Figure 2 Bland- Altman plot of the agreement between ETCO2 and 
PaCO2 at hospital arrival. 1.0kPa=7.50062 mm Hg. The bias is 1.7 (95% 
CI 1.4 to 2.0) kPa with upper and lower limits of agreement of 3.6 
(95% CI 3.0 to 4.1) kPa and −0.2 (95% CI −0.8 to 0.3) kPa, respectively. 
The bias is plotted as a single line, and the upper and lower limits of 
agreement as dashed lines. ETCO2, end- tidal carbon dioxide; PaCO2, 
arterial partial pressure of carbon dioxide.
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concentrated on hypercapnia in this study, it is encouraging 
to see that even in the presence of significant heterogeneity in 
ETCO2–PaCO2 gradient in this population, no patients were 
hypocapnic on arrival to hospital using the extant guidelines.
Even from this small sample of patients it is evident that using 
the ETCO2 as a surrogate for PaCO2 following TBI is a blunt 
tool. There is a larger than previously reported mean ETCO2–
PaCO2 gradient and only moderate correlation. The practice of 
low tidal volume ventilation may necessitate a reconsideration of 
the expected ETCO2–PaCO2 gradient, but the lack of correlation 
in those with a concomitant thoracic injury means that signifi-
cant inaccuracy in using ETCO2 as a surrogate for PaCO2 would 
likely continue. Numerous other surrogates have been used for 
PaCO2, including transcutaneous CO2 monitoring and capillary 
blood gas analysis.28 29 However, at present, an ABG sample is 
the only reliable way to obtain an accurate PaCO2 with which 
to guide ventilation in TBI. The advancement in technology and 
production of smaller, portable analyzers allow providers to 
accurately determine PaCO2 prehospital and in other resource- 
limited settings.30 31 A small number of patients in our study 
underwent prehospital measurement of PaCO2 using a POC 
analyzer. There was evidence during chart review of these seven 
patients that the providers made alterations to the ventilation 
strategy after PaCO2 analysis; they all demonstrated a favourable 
hospital arrival PaCO2.
This study used data from a single prehospital critical care 
service and a single regional neurosciences centre, and as such 
the results may not be widely applicable. In order to increase 
the number of patients in this study, we included patients who 
had an ABG up to 30 min after hospital arrival. It is therefore 
possible that a proportion of the gradient variance observed 
was due to changes in ventilation strategy during this period, 
but standard clinical practice means this should be clinically 
negligible. The availability of these data very early in this disease 
process is extremely limited, resulting in a small sample size. It is 
possible that non- significant findings are due to a lack of statis-
tical power.
CONCLUSION
There is only moderate correlation of ETCO2 and PaCO2 at 
hospital arrival in patients with serious TBI. The mean ETCO2–
PaCO2 gradient was 1.7 (±1.0) kPa (12.8 mm Hg)—greater 
than previously reported. Lower ETCO2 targets than previously 
recommended may be safe and appropriate, particularly in the 
presence of thoracic injury. There may be a role for prehospital 
PaCO2 measurement.
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